| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $40.5M | +25.4% |
| R&D Expense | $90.0M | -54.9% |
| SG&A Expense | $49.9M | -30.7% |
| Operating Income | -$160.0M | +36.3% |
| Interest Expense | $6.2M | +190.0% |
| Income Tax | $0 | — |
| Net Income | -$160.1M | +32.5% |
| EPS (Basic) | -$1.80 | +37.5% |
| EPS (Diluted) | -$1.80 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $146.6M | +11.5% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $15.2M | -6.7% |
| Current Assets | $163.9M | -43.4% |
| Total Assets | $186.5M | -45.4% |
| Current Liabilities | $46.2M | -40.1% |
| Long-term Debt | $53.6M | -6.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$165.2M | +21.4% |
| Capital Expenditures | $607K | -93.1% |
| Investing Cash Flow | $138.7M | -14.5% |
| Financing Cash Flow | $40.5M | -27.8% |
| Free Cash Flow | -$165.8M | +24.3% |
| +37.5% |
| Total Liabilities |
| $159.2M |
| -23.2% |
| Stockholders' Equity | $27.3M | -79.7% |